查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611034

食物过敏治疗市场规模、份额、趋势分析报告：按过敏原类型、按药物类型、按给药途径、按最终用途、按地区、细分市场预测，2025-2030 年

Food Allergy Treatment Market Size, Share & Trends Analysis Report By Allergen Type, By Drug Type, By Route of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

食物过敏治疗市场成长与趋势

Grand View Research, Inc.最新报告显示，到2030年，全球食物过敏治疗市场规模预计将达到113.3亿美元，预计2025年至2030年复合年增长率为8.27%。推动市场成长的关键因素包括全球食物过敏盛行率的上升以及新药研发活动的活性化。此外，采用新的生物药品来治疗食物过敏以及寻求食物过敏治疗的患者就诊次数的增加可能会推动预测期内的市场成长。

过敏治疗资金的增加正在促进创新治疗方法的研究和开发并增加可用性，满足对更有效的治疗方法和管理策略不断增长的需求。财政支持的增加正在推动市场成长，并刺激为受这种情况影响的人们开发更安全、更容易获得的解决方案。 2022年9月，临床阶段生技公司COUR Pharmaceuticals完成了由Alpha Wave Ventures领投的3,000万美元资金筹措。这笔资金筹措将支持 COUR 创新免疫修饰奈米颗粒（COUR NanoParticles 或 CNP）技术平台的扩展。此外，两项针对食物过敏治疗的概念验证测试也将取得进展。这项重要的投资凸显了推进免疫系统重编程方法来解决自体免疫疾病和食物过敏的潜力。

Xolair 和 PALFORZIA 等新药将支持市场成长。 2020年1月，FDA核准PALFORZIA标誌着食物过敏治疗的一个重要里程碑。 PALFORZIA 透过提供花生过敏的治疗选择来解决未满足的关键医疗需求。在核准之前，患者除了严格避免外，别无选择，但这项核准引入了一个可能改变生活的解决方案。这种口服免疫疗法产品专门用于减少过敏反应，包括过敏反应，这种过敏反应可能因 4 至 17 岁确诊花生过敏的儿童意外接触花生而发生。 FDA 的风险评估和缓解策略 (REMS) 要求确保 PALFORZIA 的安全和受控管理，以提高病患安全和医疗保健提供者的信心。 PALFORZIA 与避免花生的饮食结合使用，并根据患者的需要进行调整，而在气喘不受控制的情况下，嗜伊红性食道炎和其他嗜酸性粒细胞胃肠道疾病是禁忌的，这进一步强调了其对特定患者族群的安全性和适用性。

然而，雀巢的 Palforzia 面临重大挑战。儘管其研发花费了 26 亿美元，但这种治疗方法对许多潜在患者来说还是很麻烦。当 Palforzia 于 2020 年上市时，医生最初很高兴向患者提供该药物。然而，COVID-19 大流行打乱了面对面治疗计划。因此，医生决定向大约 1,000 名患者介绍这种新药，作为疫情后的选择。令人惊讶的是，只有六人表示对这种治疗感兴趣，这种治疗被誉为治疗危及生命的花生过敏的有效解决方案，并已获得美国当局的批准。即使多年后，许多医生仍然不开立 Palforzia 处方。在美国各地，医生和患者似乎都选择传统方法来避免过敏原并携带肾上腺素注射剂以备不时之需。在一项重大的市场开发中，雀巢于 2023 年 9 月将其 Palforzia 业务出售给过度诊断和治疗专家 Stallergenes Greer。这项策略性倡议是继雀巢先前宣布对 Palforzia 进行全面改革之后，作为协议的一部分，雀巢将获得里程碑付款和持续的特许权使用费。

食物过敏治疗市场报告亮点

  • 按过敏原类型划分，花生细分市场处于领先地位，到 2024 年，其销售份额最高可达 20.55%。推动市场成长的关键因素包括全球花生过敏盛行率的上升以及新药研发活动的活性化。此外，越来越多地采用新的生物药品来治疗过敏，以及增加寻求治疗这种过敏的患者就诊次数，预计也将在预测期内推动市场成长。
  • 按药物类型划分，肾上腺素细分市场在 2024 年以 41.0% 的最大销售份额引领市场。肾上腺素被认为是治疗过敏症状的首选药物。这是因为它被用作紧急过敏症状的初始治疗。
  • 从给药途径来看，口服给药预计在预测期内将以稳定的复合年增长率成长。口服食物过敏治疗主要采用口服免疫疗法（OIT），其中包括逐渐摄取受控剂量的食物过敏原。
  • 按最终用途划分，医院药房细分市场占据最大收益占有率，2024 年将达到 55.48%。医院药局是重要的分销管道，有助于提供和有效分配基本药物和治疗方法，以管理医院内的食物过敏。
  • 北美地区在 2024 年以 39.14% 的收益占有率占据市场主导地位。由于人们越来越了解过敏治疗的巨大潜力，该地区占据了主要的市场占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章食物过敏治疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 食物过敏治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章食物过敏治疗市场：依过敏原类型估计与趋势分析

  • 细分仪表板
  • 全球食物过敏治疗市场过敏原类型波动分析
  • 2018-2030年全球食物过敏治疗市场规模及趋势分析（依过敏原型态）
  • 乳製品
  • 家禽产品
  • 坚果
  • 花生
  • 贝类
  • 小麦
  • 大豆
  • 其他的

第五章食物过敏治疗市场：依药物类型估算与趋势分析

  • 细分仪表板
  • 全球食物过敏治疗市场药物种类波动分析
  • 2018-2030年全球食物过敏治疗市场规模及趋势分析（依药物类型）
  • 抗组织胺药
  • 肾上腺素
  • 免疫疗法
    • 索莱尔
    • 帕尔福齐亚
    • 其他的

第六章食物过敏治疗市场：依给药途径估计与趋势分析

  • 细分仪表板
  • 全球食物过敏治疗市场波动分析
  • 2018-2030年全球食物过敏治疗市场规模与趋势分析（依给药途径）
  • 肠外给药
  • 口服给药
  • 其他的

第七章食物过敏治疗市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 全球食物过敏治疗市场波动分析
  • 2018-2030 年全球食物过敏治疗市场规模与趋势分析（依最终用途）
  • 医院药房
  • 零售药房
  • 其他的

第八章食物过敏治疗市场：按地区估计和趋势分析

  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 2024年主要企业市场占有率分析
    • Sanofi SA
    • Stallergenes Greer
    • DBV Technologies
    • Vedanta Biosciences, Inc.
    • Alladapt Immunotherapeutics, Inc.
    • COUR Pharmaceuticals
    • Aravax
    • Prota Therapeutics Pty Ltd
    • Teva Pharmaceuticals Industries Ltd.
    • F. Hoffman-La Roche Ltd.
    • Novartis AG

第10章结论

Product Code: GVR-4-68040-290-8

Food Allergy Treatment Market Growth & Trends:

The global food allergy treatment market size is anticipated to reach USD 11.33 billion by 2030 and is projected to grow at a CAGR of 8.27% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors propelling the market growth includes the rising prevalence of food allergies worldwide and increasing R&D activities for novel drugs. Moreover, the adoption of new biological agents to treat food allergies and an increase in clinic visits by patients seeking therapy for food allergies are likely to drive the market growth over the forecast period.

The increase in funding for allergy treatments is driving advancements in research, development, and accessibility of innovative therapies, addressing the growing demand for more effective treatments & management strategies. This heightened financial support is propelling market growth and fueling the development of safer and more accessible solutions for those affected by this condition. In September 2022, COUR Pharmaceuticals, a clinical-stage biotechnology company, completed a USD 30 million financing round, with Alpha Wave Ventures as the lead investor. This funding will support the expansion of COUR's innovative immune-modifying nanoparticles (COUR NanoParticles or CNPs) technology platform. Furthermore, it will facilitate the progression of the company's two human proof-of-concept studies focused on treating food allergies. This significant investment highlights the potential for advancing immune system reprogramming approaches to address autoimmune disorders and food allergies.

Novel drugs such as Xolair, and PALFORZIA boost the market growth. In January 2020, the FDA's approval of PALFORZIA marked a significant milestone in Food Allergy Treatment. PALFORZIA addresses a crucial unmet medical need by providing a treatment option for peanut allergies. Prior to its approval, patients had limited choices beyond strict avoidance, and this approval introduced a potentially life-changing solution. This oral immunotherapy product is specifically indicated for mitigating allergic reactions, including anaphylaxis that might occur from accidental peanut exposure in children aged 4 to 17 years with a confirmed diagnosis of peanut allergy. The FDA's requirement for a Risk Evaluation and Mitigation Strategy (REMS) ensures the safe and controlled administration of PALFORZIA, boosting patient safety and healthcare provider confidence. PALFORZIA, used alongside a peanut-avoidant diet, is tailored to meet the needs of patients while being contraindicated in cases of uncontrolled asthma and eosinophilic esophagitis and other eosinophilic gastrointestinal diseases, further emphasizing its safety and suitability for specific patient populations.

However, Nestle's Palforzia faced significant challenges. Despite a substantial investment of USD 2.6 billion in its development, the treatment regimen proved to be too cumbersome for many potential patients. When Palforzia entered the market in 2020, physicians were initially excited to offer it to their patients. However, the COVID-19 pandemic disrupted in-person treatment plans. As a result, doctors resorted to informing approximately 1,000 patients about the new drug as an option for postpandemic use. Surprisingly, only six individuals expressed interest in the treatment that had been heralded as an efficient solution for life-threatening peanut allergy, having received clearance from U.S. authorities. Even after three years, many physicians have not prescribed Palforzia. Across the U.S., it appears that doctors & patients are opting for the traditional approach of avoiding allergens and carrying adrenaline injections for emergencies instead. As a significant development in the market, in September 2023, Nestle divested its Palforzia business to Stallergenes Greer, a company specifying in allergy diagnosis and treatment. This strategic move followed Nestle's earlier announcement of a review of Palforzia, with Nestle set to receive milestone payments and ongoing royalties as part of the agreement.

Food Allergy Treatment Market Report Highlights:

  • By allergen type, the peanuts segment led the market with the largest revenue share of 20.55% in 2024. Key factors propelling market growth include, rising prevalence of peanut allergies worldwide and increasing R&D activities for novel drugs. Moreover, growing adoption of new biological agents to treat allergies and an increase in clinic visits by patients seeking therapy for this allergy are likely to drive the market growth over the forecast period
  • Based on drug type, the epinephrine segment led the market with the largest revenue share of 41.0% in 2024. Epinephrine is considered to be the medication of choice for treatment of allergic conditions. Owing to its use as the initial treatment of choice for emergency allergic conditions
  • By route of administration, the oral segment is projected to grow at a steady CAGR over the forecast period. Oral food allergy treatment primarily employs Oral Immunotherapy (OIT), involving the gradual consumption of controlled amounts of food allergen
  • By end use, the hospital pharmacies segment held the market with the largest revenue share of 55.48% in 2024. Hospital pharmacies serve as a critical distribution channel, facilitating the availability and efficient dispensation of medications and treatments essential for managing food allergies within a hospital environment
  • North America dominated the market with the revenue share of 39.14% in 2024. The region held a major market share due to an increase in understanding of the high potential associated with allergy drugs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Allergen Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Food Allergy Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of peanut allergy
      • 3.2.1.2. Increasing funding for novel drug discovery
      • 3.2.1.3. Rising awareness programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment and products
  • 3.3. Food Allergy Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Food Allergy Treatment Market: Allergen Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Food Allergy Treatment Market by Allergen Type Outlook
  • 4.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Million)
  • 4.4. Dairy Products
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Poultry Product
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Tree Nuts
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Peanuts
    • 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Shellfish
    • 4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Wheat
    • 4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Wheat
    • 4.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Soys
    • 4.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Other
    • 4.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Food Allergy Treatment Market: Drug Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Food Allergy Treatment Market Drug Type Movement Analysis
  • 5.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
  • 5.4. Antihistamines
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Epinephrine
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Immunotherapy
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.2. Xolair
      • 5.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.3. PALFORZIA
      • 5.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Food Allergy Treatment Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Food Allergy Treatment Market Movement Analysis
  • 6.3. Global Food Allergy Treatment Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Parenteral Route
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Oral Route
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Food Allergy Treatment Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Food Allergy Treatment Market Movement Analysis
  • 7.3. Global Food Allergy Treatment Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Retail Pharmacies
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Food Allergy Treatment Market: Regional Estimates & Trend Analysis by

  • 8.1. Regional Market Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Sanofi SA
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Stallergenes Greer
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. DBV Technologies
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Vedanta Biosciences, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Alladapt Immunotherapeutics, Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. COUR Pharmaceuticals
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Aravax
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Prota Therapeutics Pty Ltd
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Teva Pharmaceuticals Industries Ltd.
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. F. Hoffman-La Roche Ltd.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Novartis AG
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives

Chapter 10. Conclusion

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 5 North America Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 6 North America Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7 North America Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Canada Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 Mexico Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Europe Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Germany Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 UK Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 30 UK Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 31 UK Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 32 UK Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 France Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 34 France Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 35 France Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 France Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Italy Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 40 Italy Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Spain Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Sapin Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Denmark Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 Denmark Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Sweden Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 Sweden Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Norway Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Norway Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Japan Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Japan Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 China Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 67 China Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 68 China Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 China Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 India Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 71 India Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 72 India Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 India Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Australia Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 75 Australia Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Australia Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 South Korea Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 79 South Korea Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 81 South Korea Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Thailand Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 Thailand Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Latin America Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 88 Latin America Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 90 Latin America Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Brazil Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Brazil Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 95 Argentina Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 96 Argentina Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 98 Argentina Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 99 MEA Food Allergy Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 100 MEA Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 101 MEA Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 102 MEA Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 103 MEA Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 South Africa Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 105 South Africa Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 107 South Africa Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 UAE Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 113 UAE Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 115 UAE Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Food Allergy Treatment Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Food Allergy Treatment Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Food Allergy Treatment Market snapshot (2023)
  • Fig. 9 Food Allergy Treatment Market: Segment snapshot (2023)
  • Fig. 10 Competitive Insights (2023)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Food Allergy Treatment Market driver impact
  • Fig. 15 Food Allergy Treatment Market restraint impact
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 18 Strategic alliance analysis
  • Fig. 19 Recent developments & impact analysis, by key market participants
  • Fig. 20 Key company market share analysis, 2024
  • Fig. 21 Company market position analysis
  • Fig. 22 Definition and scope, by Allergen Type
  • Fig. 23 Allergen Type market share analysis, 2024 & 2030
  • Fig. 24 Global Food Allergy Treatment Market, by Allergen Type, 2018 - 2030 (USD Million)
  • Fig. 25 Dairy Products market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 26 Poultry Product market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 27 Tree Nuts market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Peanuts market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Shellfish market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Wheat market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Soys market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Other market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Definition and scope, by drug type
  • Fig. 34 Drug type market share analysis, 2024 & 2030
  • Fig. 35 Global Food Allergy Treatment Market, by drug type, 2018 - 2030 (USD Million)
  • Fig. 36 Antihistamines market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 37 Epinephrine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Immunotherapy market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Xolair market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 PALFORZIA NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 Other immunotherapies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 42 Definition and scope, by Route of Administration
  • Fig. 43 Route of Administration market share analysis, 2024 & 2030
  • Fig. 44 Global Food Allergy Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 45 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Definition and scope, by End Use
  • Fig. 49 End Use market share analysis, 2024 & 2030
  • Fig. 50 Segment dashboard
  • Fig. 51 Global Food Allergy Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Fig. 52 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 53 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 54 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 55 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 58 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 59 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 60 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 61 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 62 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 63 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 64 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 65 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 66 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 67 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 68 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 71 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 72 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 73 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 74 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 78 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)